Baidu
map

Stroke:西洛他唑与阿司匹林对缺血性卒中高危脑出血患者的疗效比较

2019-12-23 xing.T MedSci原创

由此可见,西洛他唑对存在多种脑微出血且在白质广泛变化之前的缺血性卒中患者可能更有益。

尽管西洛他唑的出血事件少于阿司匹林,但在脑出血高风险患者中,出血性卒中事件仅观察到细微的差异。为了确定最能从西洛他唑治疗中获益的患者,近日,心血管疾病领域权威杂志Stroke上发表了一篇研究文章,该研究分析了PICASSO(脑出血高风险亚洲缺血性卒中患者的心血管事件预防)试验治疗与亚组之间的相互作用。

既往有脑出血或多次微出血的缺血性卒中患者被随机分配接受西洛他唑或阿司匹林治疗,平均随访1.8年。在两组中分析了疗效(定义为任何卒中、心肌梗塞和血管死亡的综合事件)和安全性(定义为出血性卒中的发生率)。研究人员分析了治疗与年龄、性别、高血压糖尿病的情况、高危脑出血指数以及白质病变负担之间的相互作用,以评估主要和次要结局。比较两组的生命体征变化和实验室检查结果。

在所有纳入的1534名患者中,观察到治疗组与出血性脑卒中患者脑出血高风险指数之间存在显著的相互作用(相互作用P为0.03)。多发性微出血患者中,西洛他唑组的出血性卒中发生率低于阿司匹林组(1 vs. 13次事件;风险比为0.08[95%CI为0.01-0.61];P=0.01)。研究人员观察到任何卒中治疗组和白质变化之间微弱的相互作用(相互作用P=0.08)。西洛他唑可降低(5例 vs. 16例事件;风险比为0.36 [95%CI为0.13-0.97]; P=0.04)至中度(16例 vs. 32例;风险比为0.50 [95%CI为0.29-0.92];P=0.03)白质变化患者的卒中风险。随访时,西洛他唑组的心率和HDL(高密度脂蛋白)胆固醇水平显著高于阿司匹林组。

由此可见,西洛他唑对存在多种脑微出血且在白质广泛变化之前的缺血性卒中患者可能更有益。

原始出处:

Bum Joon Kim.et al.Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage Subgroup Analysis of the PICASSO Trial.stroke.2019.https://www.ahajournals.org/doi/10.1161/STROKEAHA.119.023855

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1822250, encodeId=6aff1822250ac, content=<a href='/topic/show?id=4faa1022e209' target=_blank style='color:#2F92EE;'>#高危脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102272, encryptionId=4faa1022e209, topicName=高危脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Apr 08 20:45:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893243, encodeId=f1ab1893243a8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 05 03:45:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806366, encodeId=0da7180636660, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri Jul 24 20:45:00 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377366, encodeId=80533e7366c8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Dec 24 09:53:34 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026521, encodeId=943a1026521bf, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032366, encodeId=037a103236650, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1822250, encodeId=6aff1822250ac, content=<a href='/topic/show?id=4faa1022e209' target=_blank style='color:#2F92EE;'>#高危脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102272, encryptionId=4faa1022e209, topicName=高危脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Apr 08 20:45:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893243, encodeId=f1ab1893243a8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 05 03:45:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806366, encodeId=0da7180636660, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri Jul 24 20:45:00 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377366, encodeId=80533e7366c8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Dec 24 09:53:34 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026521, encodeId=943a1026521bf, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032366, encodeId=037a103236650, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1822250, encodeId=6aff1822250ac, content=<a href='/topic/show?id=4faa1022e209' target=_blank style='color:#2F92EE;'>#高危脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102272, encryptionId=4faa1022e209, topicName=高危脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Apr 08 20:45:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893243, encodeId=f1ab1893243a8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 05 03:45:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806366, encodeId=0da7180636660, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri Jul 24 20:45:00 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377366, encodeId=80533e7366c8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Dec 24 09:53:34 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026521, encodeId=943a1026521bf, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032366, encodeId=037a103236650, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1822250, encodeId=6aff1822250ac, content=<a href='/topic/show?id=4faa1022e209' target=_blank style='color:#2F92EE;'>#高危脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102272, encryptionId=4faa1022e209, topicName=高危脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Apr 08 20:45:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893243, encodeId=f1ab1893243a8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 05 03:45:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806366, encodeId=0da7180636660, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri Jul 24 20:45:00 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377366, encodeId=80533e7366c8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Dec 24 09:53:34 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026521, encodeId=943a1026521bf, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032366, encodeId=037a103236650, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
    2019-12-24 天地飞扬

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1822250, encodeId=6aff1822250ac, content=<a href='/topic/show?id=4faa1022e209' target=_blank style='color:#2F92EE;'>#高危脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102272, encryptionId=4faa1022e209, topicName=高危脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Apr 08 20:45:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893243, encodeId=f1ab1893243a8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 05 03:45:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806366, encodeId=0da7180636660, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri Jul 24 20:45:00 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377366, encodeId=80533e7366c8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Dec 24 09:53:34 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026521, encodeId=943a1026521bf, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032366, encodeId=037a103236650, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
    2019-12-24 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1822250, encodeId=6aff1822250ac, content=<a href='/topic/show?id=4faa1022e209' target=_blank style='color:#2F92EE;'>#高危脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102272, encryptionId=4faa1022e209, topicName=高危脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Apr 08 20:45:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893243, encodeId=f1ab1893243a8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 05 03:45:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806366, encodeId=0da7180636660, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri Jul 24 20:45:00 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377366, encodeId=80533e7366c8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Dec 24 09:53:34 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026521, encodeId=943a1026521bf, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032366, encodeId=037a103236650, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Dec 24 01:45:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
    2019-12-24 内科新手

    谢谢梅斯提供这么好的信息,学到很多

    0

相关资讯

Lancet Neurol:脑出血高风险者如何选用抗血小板和降脂药物?

卒中是全球的重要健康问题,特别是亚洲国家的卒中死亡率高于非亚洲国家。并且卒中的主要病因和机制也不相同,亚洲人比白种人更容易发生脑出血。此外,小血管闭塞性疾病也更常见于亚洲人,心源性卒中更常见于白色人种。

Circulation:添加西洛他唑强化抗血小板治疗可显著改善对氯吡格雷不敏感的患者预后

经皮冠状动脉介入治疗的患者对抗血小板药物的反应不同。对氯吡格雷反应不敏感的患者心脏缺陷事件风险高。Yi-Da Tang等人在单中心进行随机化的对照试验,对比强化的抗血小板疗法(两倍剂量的氯吡格雷[DOUBLE]或添加西洛他唑[TRIPLE])与常规疗法(STANDARD)用于经皮冠状动脉介入治疗后的患者的疗效和安全性。研究人员根据血栓弹力图(一种血小板功能检测)挑选了1078例经皮冠状动脉介入治疗

Circulation:阜外医院唐熠达教授牵头CREATIVE研究:“新三联”抗血小板治疗安全有效

2月2日,Circulation杂志在线发表了中国医学科学院阜外医院唐熠达教授牵头的CREATIVE研究结果,该研究完全由我国学者自行设计和完成。

JNS:西洛他唑预防SAH后慢性脑积水

动脉瘤蛛网膜下腔出血(aSAH)的慢性分流-依赖性脑积水(Chronic shunt-dependent hydrocephalus)发生率为8.9%-48%。SAH后慢性脑积水与不良神经功能预后有关,并且CSF分流不能完全逆转脑积水。大量回顾性研究探讨了SAH相关分流依赖性慢性脑积水的预测因素。夹闭动脉瘤时进行终板开窗有可能降低分流依赖慢性脑积水的发生率,但是其疗效存在争议。据我们所知,目前尚无

Diabetes Obes Metab:西洛他唑对2型糖尿病患者冠状动脉狭窄和斑块特征的影响

由此可见,西洛他唑治疗12个月可减少冠状动脉狭窄和非钙化斑块成分。这些结果表明西洛他唑治疗可能是预防糖尿病患者冠状动脉粥样硬化进展的一种选择。

EClinical Medicine:单硝酸异山梨醇和西洛他唑治疗腔隙性卒中

研究认为,在腔隙性脑卒中患者中,西洛他唑和ISMN在剂量增加的情况下是耐受性好的,不存在安全问题

Baidu
map
Baidu
map
Baidu
map